Picornaviridae (Order Picornavirales) is a large, diverse family of small, non-enveloped, icosahedral RNA viruses with spherical 20–30 nm diameter nucleocapsids and a single-stranded, positive-sense RNA genome ranging between 6.7 and 10.1 kb in size1. The highly diverse genome consists of a distinguishing characteristic long 5’ UTR with an internal ribosomal entry site (IRES) 250–450 nucleotide upstream of the translational start site, a single ORF encoding a polyprotein, a shorter 3’ UTR, and a poly-A tail. However, the genome of Dicipiiviruses (genus Dicipivirus) has two ORFs, each with its own IRES. Based on its secondary structure, most picornavirus IRES elements are currently classified into five types (I-V, IGR-IRES). Picornaviridae is constantly adding new members due to advances in next-generation sequence technology and testing of clinical and environmental samples2 and is considered to include 68 genera and 158 species as of Sept. 11, 2023, date of the latest International Committee on the Taxonomy of Viruses (ICTV) master species list. Picornaviruses infect a wide range of hosts, including amphibians, reptiles, fish, birds, humans, and other mammalian species, including marine mammals. Infections are usually mild and subclinical, but more severe presentations include fever, diseases of the heart, nervous system, respiratory tract, gastrointestinal tract, liver, and vesicles on mucocutaneous tissues2,3. Some examples of human diseases include the common cold associated with rhinovirus A, B, and C4, poliomyelitis caused by poliovirus5, and hepatitis A caused by hepatovirus6. Picornaviruses are also the cause of notable veterinary diseases, including foot-and-mouth disease (FMD), which causes enormous economic losses in swine and cattle industries worldwide7, and Senecavirus-associated vesicular disease (SAVD) of swine, which presents as clinically identical to FMD in swine, necessitating confirmatory diagnostic testing8.
Senecavirus A (SVA) was first isolated in the human primary embryonic retinoblastoma cell line PER.C6 as a rapidly growing tissue culture contaminant in 2002, likely from a contaminated porcine trypsin reagent. SVA is capable of in vitro growth in several cell lines, including those of porcine and non-porcine origin, i.e., porcine kidney-15 (PK-15), swine testis (ST), human primary embryonic retinoblastoma cell line (PER.C6), and a human lung cancer cell line (NCI-H1299). Purified virus sample and virus-infected PER.C6 cells revealed icosahedral particles of about 27 nm in diameter, consistent with other members of the Picornaviridae. Subsequently, more isolates were isolated, including an isolate from a buffalo (Bubalus bubalis) from China9, and genome sequencing confirmed it as a novel monotypic genus within the family Picornaviridae, and most closely related to the genus Cardiovirus10. Among SVA’s other notable attributes are that it is incapable of integrating into human genomic DNA during infection and its ability to selectively infect and kill human tumor cells after some genetic modification, making SVA an ideal virus for developing oncolytic virus cancer therapies11.
It was not until 2007 that SVA was shown to be responsible for vesicular disease and lameness in a shipment of pigs from Manitoba, Canada12. The vesicles were indistinguishable from those caused by FMD, swine vesicular disease (SVD), vesicular stomatitis (VS), and vesicular exanthema (VE), but when vesicle material was tested, they were only positive for SVA, confirming its ability to cause these clinical manifestations. It was also associated with new clinical presentations, such as diarrheal disease in newborn piglets and neonatal mortality, suggesting it was becoming more pathogenic13. From 2007 to 2015, SVA was detected sporadically in pigs in the USA and Brazil. However, after 2015, SVA spread rapidly to Asia, the UK, as well as Mexico, Colombia, and Chile in the Americas, causing severe problems in sows and finishing pigs in China, in addition to neonatal mortality14. To date, many aspects of SVA’s biology, including its origin, natural reservoirs and transmission pathways, remain unknown. However, the detection of SVA neutralizing antibody, SVA in mice small intestine, feces and genomic material in flies from unaffected farms suggest they may play a role in its epidemiology15.
Several picornaviruses have been characterized from phocids and a single cetacean. The majority of these viruses were described from metagenomic surveys, but some have been cultured, including harbor seal (Phoca vitulina) picornavirus (HsPV) and ribbon seal (Histriophoca fasciata) picornavirus (RsPV)16; ringed seal (Phoca hispida) picornavirus 1 (SePV-1)17, and Weddell seal (Leptonychotes weddellii)18. Whereas sub-Antarctic fur seal (Arctocephalus tropicalis) sakobuvirus, fur seal (Arctocephalinae spp.) picorna-like virus, South American fur seal (Arctocephalus australis) picornavirus19; harbor seal phopivirus, harbor seal Hepatovirus B20; California sea lion (Zalophus californianus) sapelovirus 1 and 221, Fur seal picorna-like virus from Arctocephalus gazelle22 have not been isolated in cell culture. A single report of a picornavirus having been cultured from a cetacean, the bottlenose dolphin Tursiops truncatus (bottlenose dolphin enterovirus) was previously described23. The partial genome sequence of a picornavirus from a captive beluga, HMU-1, has also been reported24. The role of marine mammal picornavirus infection in causing disease is presently unknown. SePV-1 was isolated from a nasal swab of a hunter-harvested, apparently healthy, ringed seal from arctic Canada17, while HsPV and RsPV were both isolated from dead stranded seals but what role the infection had in contributing to their death is unclear16. In this study, we report the first isolation of picornaviruses from harbor porpoise and beluga, sequenced the complete genomes, and performed phylogenetic/genetic analyses that demonstrated these cetacean picornaviruses represent a novel species.